Amcor Announces Breakthrough Healthcare Lidding Technology for Combination Products
Amcor has launched a new proprietary healthcare lidding technology designed for combination products, encompassing devices and drugs. This patented inert film withstands heat sterilization and prevents drug uptake, enhancing product integrity and usability. The technology is the result of collaboration with Johnson & Johnson Vision and aims to improve packaging solutions for active pharmaceutical ingredients. With 47,000 employees and $12.5 billion in sales, Amcor continues to expand its innovative healthcare offerings.
- Launch of proprietary healthcare lidding technology enhances product offering.
- Collaboration with Johnson & Johnson Vision leverages expertise for product development.
- Technology ideal for combination products, ensuring integrity and usability.
- None.
ZURICH, Aug. 11, 2021 /PRNewswire/ -- Amcor, a global leader in developing and producing a diverse offering of responsible packaging solutions, today announced the launch of a proprietary healthcare lidding technology that will be utilized for combination products – those consisting of two or more regulated components (device, drug or biologic).
This latest innovation from Amcor is based on a patented inert film development and laminate design. It provides a lidding solution that can withstand heat sterilization, the process of preserving and sterilizing items, while preventing drug uptake into the packaging. The packaging solution is ideal for combination healthcare products, such as devices with an Active Pharmaceutical Ingredient (API) that forms the basis of a medicine. It ensures machinability, integrity after sterilization, as well as a convenient peel opening for patients. The features of the new product complement Amcor's existing healthcare portfolio, which range from lidding for demanding sterilization environments to high barrier overwraps protecting eye droppers and medications for the eye.
Amcor collaborated with Johnson & Johnson Vision over the course of several years to develop the lidding technology for use with contact lenses. Each company contributed specific skills and perspective, notably Amcor's expertise with film extrusion, lamination and conversion for healthcare, and J&J Vision's expertise on ophthalmic device packaging requirements.
Peter Konieczny, Amcor's Chief Commercial Officer said: "We are bringing together industry-leading innovation and close customer relationships to develop the packaging solutions of the future. With this next-generation healthcare lidding technology we are opening a world of possibilities for products using active pharma ingredients. We look forward to extending this differentiated lidding technology to additional combination products in the future."
To find out more about Amcor's innovative healthcare packaging solutions go to www.amcor.com/healthcare.
About Amcor Amcor is a global leader in developing and producing responsible packaging for food, beverage, pharmaceutical, medical, home- and personal-care, and other products. Amcor works with leading companies around the world to protect their products and the people who rely on them, differentiate brands, and improve supply chains through a range of flexible and rigid packaging, specialty cartons, closures, and services. The company is focused on making packaging that is increasingly light-weighted, recyclable and reusable, and made using an increasing amount of recycled content. Around 47,000 Amcor people generate US
www.amcor.com I LinkedIn I Facebook I Twitter I YouTube
View original content to download multimedia:https://www.prnewswire.com/news-releases/amcor-announces-breakthrough-healthcare-lidding-technology-for-combination-products-301353135.html
SOURCE Amcor
FAQ
What is the new healthcare lidding technology launched by Amcor?
How does Amcor's new lidding technology benefit pharmaceutical packaging?
Which company collaborated with Amcor on the new lidding technology?
What is the stock symbol for Amcor?
When was Amcor's new lidding technology announced?
